CVN-45502

N/A

Report date: 2025/01/26 18:09:05
NME

Base Information

Drug NameCVN-45502
Drug Alias NameHCRTR1 antagonist (Cerevance/Rockefeller University)hypocretin receptor 1 antagonist (Cerevance/Rockefeller University)orexin receptor type 1 antagonist (Cerevance/Rockefeller University)CVN-45502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOrexin receptor type 1 antagonists
TargetsOrexin receptor type 1
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe Rockefeller University
China Registration ClassN/A

Develop Information

Active CompaniesCerevance LtdThe Rockefeller University
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A